Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue
Drug safety advice
- Ceftriaxone: incompatibility with calcium-containing solutions—updated advice
- High-dose cyproterone acetate: potential risk of (multiple) meningiomas
Yellow Card Scheme update - Human papillomavirus (HPV) immunisation programme—first year safety review
Hot topics
- Smoking and smoking cessation: clinically significant interactions with commonly used medicines
- Aspirin: not licensed for primary prevention of thrombotic vascular disease
Stop press
- Varenicline and suicidal behaviour: cohort study provides some reassurance
Other information from the MHRA
- Patient Information Leaflet of the month: medicines used in tuberculosis
Drug Safety Update: Volume 3 Issue 3, October 2009 
